R J Biotech

R J Biotech EBITDA per Share

Delisted·Sep 16, 2026

The EBITDA per Share of R J Biotech (536456.BO) as of Oct 28, 2026 is 1.38 INR. In the previous year, EBITDA per Share was -13.33 INR — a change of -110.38% (higher).

EBITDA per Share

1.38INR

YoY

-110.38%

Last updated:

EBITDA per Share of R J Biotech is 2022 1.38 INR. EBITDA per Share of R J Biotech was 2021 -13.33 INR. It decreases by -110.38% higher compared to the previous year.

The R J Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2015
6.09 INR
Jan 1, 2016
6.50 INR
Jan 1, 2017
-11.78 INR
Jan 1, 2018
-8.33 INR
Jan 1, 2019
-7.79 INR
Jan 1, 2020
-3.68 INR
Jan 1, 2021
-13.33 INR
Jan 1, 2022
1.38 INR
The R J Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
1.38INR-110.38%
-13.33INR+262.36%
-3.68INR-52.80%
-7.79INR-6.44%
-8.33INR-29.30%
-11.78INR-281.26%
6.50INR+6.81%
6.09INR-16.13%
7.26INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

R J Biotech Stock analysis

What does R J Biotech do? R J Bio-Tech Ltd. generates revenue through the research, development, and commercialization of proprietary hybrid seeds. The company focuses on field crops such as Hybrid Bajra Amol, Hybrid Bajra RJBH-555, BG-II Cotton Hybrid Tukaram, Elite Paddy Janaki-1010, and Hybrid Paddy Chetak-115 (Maruti-115), as well as vegetable and oil seed crops. Its primary customers are farmers and agricultural businesses seeking high-yield, nutritionally enhanced seeds for cultivation in Maharashtra and beyond. The firm leverages its germplasm collection of over 2700 varieties and processing plants with a combined annual capacity of 45,000 MT to support seed production and distribution. The company’s product portfolio targets key agricultural segments including fiber crops like cotton, cereal crops such as paddy, maize, and bajra, and vegetable crops. By developing hybrids with specific nutritional and economic traits, R J Bio-Tech Ltd. addresses market demands for improved crop yields and quality. Its infrastructure, including three testing locations and a storage facility exceeding 40,000 square feet, ensures efficient production and quality control for its seed offerings. R J Bio-Tech Ltd. sells seeds directly to farmers and agricultural enterprises, focusing on the Indian market with a strong presence in Maharashtra. The firm’s revenue streams are derived from the sale of its proprietary seed varieties, supported by its extensive germplasm library and processing capabilities. The company’s business model emphasizes innovation in seed technology to meet the evolving needs of the agricultural sector. R J Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R J Biotech stock

EBITDA per Share of R J Biotech is 1.38 INR in 2022.

EBITDA per Share of R J Biotech changed from -13.33 INR to 1.38 INR, representing a -110.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share R J Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — R J Biotech

All Key Metrics — R J Biotech